See more : CMG Pharmaceutical Co., Ltd. (058820.KQ) Income Statement Analysis – Financial Results
Complete financial analysis of Chimera Investment Corporation (CIM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chimera Investment Corporation, a leading company in the REIT – Mortgage industry within the Real Estate sector.
- NickelX Limited (NKL.AX) Income Statement Analysis – Financial Results
- Telecom Argentina S.A. (TEO) Income Statement Analysis – Financial Results
- Specificity, Inc. (SPTY) Income Statement Analysis – Financial Results
- Patentus S.A. (PAT.WA) Income Statement Analysis – Financial Results
- Inogen, Inc. (INGN) Income Statement Analysis – Financial Results
Chimera Investment Corporation (CIM)
About Chimera Investment Corporation
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency and non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of residential, commercial mortgage loans, and other real estate related securities. It has elected to be taxed as a REIT. In addition, the company invests in investment, non-investment grade, and non-rated classes. The company was incorporated in 2007 and is based in New York, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 226.02M | 432.79M | 1.06B | 228.84M | 490.79M | 452.74M | 629.19M | 614.34M | 324.69M | 574.91M | 396.79M | 386.94M | 0.00 | 562.88M | 100.77M | 44.72M | 3.49M |
Cost of Revenue | 32.62M | 52.15M | 66.41M | 52.53M | 47.22M | 49.11M | 62.96M | 48.60M | 51.22M | 10.00M | 2.65M | 0.00 | 0.00 | 37.18M | 9.85M | 0.00 | 0.00 |
Gross Profit | 193.40M | 380.64M | 990.62M | 176.30M | 443.57M | 403.63M | 566.22M | 565.74M | 273.47M | 564.91M | 394.14M | 386.94M | 0.00 | 525.70M | 90.92M | 44.72M | 3.49M |
Gross Profit Ratio | 85.57% | 87.95% | 93.72% | 77.04% | 90.38% | 89.15% | 89.99% | 92.09% | 84.23% | 98.26% | 99.33% | 100.00% | 0.00% | 93.40% | 90.23% | 100.00% | 100.00% |
Research & Development | 0.00 | -0.74 | 0.69 | 0.13 | 0.42 | 0.32 | 0.47 | 0.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 25.12M | 72.03M | 69.07M | 70.16M | 75.44M | 59.05M | 47.86M | 44.42M | 42.18M | 31.81M | 16.73M | 13.99M | 59.24M | 46.94M | 29.77M | 14.03M | 605.00K |
Selling & Marketing | 30.57M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -20.01M | -8.43M | 0.00 |
SG&A | 55.69M | 72.03M | 69.07M | 70.16M | 75.44M | 59.05M | 47.86M | 44.42M | 42.18M | 31.81M | 16.73M | 13.99M | 59.24M | 46.94M | 9.75M | 5.60M | 605.00K |
Other Expenses | 0.00 | -810.41M | -451.58M | -209.98M | -152.48M | 753.95M | 526.14M | 385.58M | 367.21M | 23.78M | 72.31M | 156.49M | 5.29M | 2.69M | 3.10M | 0.00 | 5.40M |
Operating Expenses | 55.69M | 22.65M | -382.51M | -139.82M | -77.05M | 813.00M | 574.00M | 430.00M | 434.00M | 387.00M | 115.00M | 220.00M | 64.53M | 49.63M | 11.45M | 14.03M | -5.37M |
Cost & Expenses | 88.31M | 22.65M | -382.51M | -139.82M | -77.05M | 813.00M | 574.00M | 430.00M | 434.00M | 387.00M | 115.00M | 220.00M | 64.53M | 86.80M | 21.29M | 14.03M | -5.37M |
Interest Income | 772.90M | 773.12M | 937.55M | 1.03B | 1.36B | 1.27B | 1.14B | 934.07M | 872.74M | 687.80M | 511.78M | 589.44M | 134.86M | 115.06M | 35.08M | 60.54M | 0.00 |
Interest Expense | 509.54M | 333.29M | 326.63M | 516.18M | 758.81M | 679.11M | 532.75M | 347.86M | 259.37M | 147.79M | 102.00M | 126.56M | 134.86M | 115.06M | 35.08M | 60.54M | 0.00 |
Depreciation & Amortization | 0.00 | 869.60M | -301.84M | 32.53M | -180.77M | 202.69M | -48.56M | -16.63M | -363.76M | -521.16M | -362.69M | -327.77M | 337.32M | 735.47M | -49.25M | -45.23M | -98.00K |
EBITDA | 0.00 | -191.80M | 674.52M | 89.01M | 413.74M | 1.09B | 1.06B | 899.88M | 509.72M | 736.99M | 464.69M | 258.81M | 629.90M | 685.84M | 284.73M | -119.80M | -2.58M |
EBITDA Ratio | 0.00% | -44.32% | 63.81% | 38.90% | 84.30% | 240.94% | 168.08% | 146.48% | 156.99% | 128.19% | 117.11% | 117.42% | 0.00% | 121.85% | 307.47% | -132.51% | -85.88% |
Operating Income | 631.87M | -253.29M | 674.52M | 89.01M | 413.74M | 1.09B | 1.06B | 899.88M | 509.72M | 736.99M | 464.69M | 454.33M | -64.53M | -49.63M | -32.87M | -14.03M | 8.87M |
Operating Income Ratio | 279.56% | -58.52% | 63.81% | 38.90% | 84.30% | 240.94% | 168.08% | 146.48% | 156.99% | 128.19% | 117.11% | 117.42% | 0.00% | -8.82% | -32.62% | -31.37% | 253.87% |
Total Other Income/Expenses | -505.67M | -336.19M | -313.41M | -533.45M | -361.34M | 16.77M | -629.88M | 16.48M | -113.41M | 68.05M | 0.00 | 0.00 | -491.96M | -278.29M | 16.00M | -89.94M | -11.77M |
Income Before Tax | 126.21M | -513.32M | 674.52M | 89.01M | 413.74M | 411.73M | 524.78M | 552.03M | 250.35M | 589.21M | 362.69M | 327.77M | 137.94M | 533.61M | 95.47M | -119.80M | -2.90M |
Income Before Tax Ratio | 55.84% | -118.61% | 63.81% | 38.90% | 84.30% | 90.94% | 83.41% | 89.86% | 77.10% | 102.49% | 91.41% | 84.71% | 0.00% | 94.80% | 94.74% | -267.91% | -83.08% |
Income Tax Expense | 102.00K | -253.00K | 4.41M | 158.00K | 193.00K | 91.00K | 108.00K | 83.00K | 1.00K | 2.00K | 2.00K | 1.00K | 606.00K | 756.00K | 1.00K | 12.00K | 5.00K |
Net Income | 126.10M | -513.07M | 670.11M | 88.85M | 413.55M | 411.64M | 524.67M | 551.94M | 250.35M | 589.21M | 362.69M | 327.77M | 137.33M | 532.85M | 95.47M | -119.81M | -2.91M |
Net Income Ratio | 55.79% | -118.55% | 63.40% | 38.83% | 84.26% | 90.92% | 83.39% | 89.84% | 77.10% | 102.49% | 91.41% | 84.71% | 0.00% | 94.67% | 94.74% | -267.94% | -83.22% |
EPS | 0.68 | -2.19 | 2.55 | 0.42 | 1.82 | 2.20 | 2.62 | 2.93 | 1.25 | 2.87 | 1.77 | 1.60 | 0.67 | 3.24 | 0.94 | -9.49 | -0.39 |
EPS Diluted | 0.68 | -2.19 | 2.43 | 0.39 | 1.81 | 2.19 | 2.61 | 2.92 | 1.25 | 2.87 | 1.76 | 1.60 | 0.67 | 3.24 | 0.94 | -9.49 | -0.39 |
Weighted Avg Shares Out | 76.69M | 233.94M | 233.77M | 213.00M | 187.16M | 187.15M | 187.78M | 187.73M | 199.56M | 205.45M | 205.42M | 205.37M | 205.27M | 164.34M | 101.19M | 12.63M | 7.48M |
Weighted Avg Shares Out (Dil) | 77.54M | 233.94M | 245.50M | 226.44M | 188.41M | 187.75M | 188.29M | 188.02M | 199.65M | 205.51M | 205.51M | 205.50M | 205.43M | 164.52M | 101.41M | 12.63M | 7.48M |
2 Big Dividend Yielders And My Rant About Accounting
Mortgage REITs Surging
12%+ Dividend Yields Duel
4 Double-Digit Dividend Distributors
3 Top Dividend Stocks With Yields Over 10% to Buy Now
Chimera Investment: Great Value, Extreme Discount To Book
Chimera Preferreds Yield Over 11% With Fundamentally Medium Risk
The Preferred Stock Of Chimera Investment Remains Highly Attractive For Income-Oriented Investors
12% Dividend Yield Sure Beats 8%
Chimera (CIM) Stock Jumps 7.5%: Will It Continue to Soar?
Source: https://incomestatements.info
Category: Stock Reports